WHO Drug Information Vol. 15, No. 2, 2001
(2001; 91 pages) View the PDF document
Table of Contents
Open this folder and view contentsPersonal Perspectives
Open this folder and view contentsReports on Individual Drugs
Open this folder and view contentsVaccines and Biomedicines
Open this folder and view contentsCurrent Topics
Open this folder and view contentsGeneral Information
Open this folder and view contentsRegulatory and Safety Matters
Close this folderATC/DDD Classification
View the documentATC/DDD Classification (final)
View the documentATC/DDD Classification (temporary)
Open this folder and view contentsEssential Drugs
Open this folder and view contentsRecent Publications and Sources of Information
View the documentInternational Nonproprietary Names for Pharmaceutical Substances (INN)
View the documentDénominations communes internationales des Substances pharmaceutiques (DCI)
View the documentDenominaciones Comunes Internacionales para las Sustancias Farmacéuticas (DCI)
View the documentAmendments to previous lists/Modifications apportées aux listes antérieures/Modificaciones a las listas anteriores
View the documentAnnexes
 

ATC/DDD Classification (final)

The following final anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place in October 2000 in the Hague. They came into force on 1 March 2001 and can be viewed on http://www.whocc.nmd.no. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/common name

ATC code

     

New ATC level codes (other than 5th level):

   
 

Drugs acting on serotonin receptors

 

A03AE

 

Streptogramins

 

J01FG

     

New ATC 5th level codes:

   
 

alosetron

A03AE01

 

benzethonium chloride, combinations

D08AJ58

 

betacarotene

A11CA02

 

betaine

A16AA06

 

betamethasone

S03BA03

 

biphenylol

D08AE06

 

bisacodyl, combinations

A06AB52

 

carglutamic acid

A16AA05

 

caspofungin

J02AX04

 

doxycycline

A01AB22

 

drospirenone and estrogen

G03AA12

 

dyclonine

R02AD04

 

dydrogesterone and estrogen

G03FA14

 

epinephrine

R01AA14

 

ethanol

D08AX08

 

Indium (111In) capromab pendetide

V09IB04

 

ioxilan

V08AB12

 

iproclozide

N06AF06

 

levetiracetam

N03AX14

 

linezolid

J01XX08

 

lopinavir

J05AE06

 

magnesium citrate

A06AD19

 

magnesium oxide

A12CC10

 

nifenazone

M02AA24

 

peginterferon alfa-2a

L03AB11

 

phenol

R02AA19

 

pyrithione zinc

D11AX12

 

quinupristin/dalfopristin

J01FG02

 

rasburicase

V03AF07

 

tegaserod

A03AE02

 

tramadol, combinations

N02AX52

 

zoledronic acid

M05BA08

     

ATC code changes

   
 

Previous:

bupropion

N06AX12

 

New:

bupropion

N07BA02

 

Previous:

glatiramer acetate

L04AA07

 

New:

glatiramer acetate

L03AX13

 

Previous:

pristinamycin

J01FA04

 

New:

pristinamycin

J01FG01

     

ATC name changes

   
 

Previous:

Macrolides and lincosamides

 
 

New:

Macrolides, lincosamides & streptogramins

J01F

 

Previous:

amfebutamone

 
 

New:

bupropion

N07BA02

     

ATC codes under evaluation

   
 

Vasopeptidase inhibitors, plain

 

C09E

 

Vasopeptidase Inhibitors, plain

 

C09EA

 

Omapatrilat

 

C09EA01

New DDDs:

INN/common name

DDD

Unit

Route of Administration

ATC code

alosetron

2

mg

O

A03AE01

atosiban

165

mg

P

G02CX01

brinzolamide

0.2

ml

 

S01EC04

bupropion

0.3

g

O

N07BA02

dihydrocodeine

0.15

g

O

N02AA08

esomeprazole

20

mg

O

A02BC05

etanercept

7

mg

P

L04AA11

infliximab

3.75

mg

P

L04AA12

levetiracetam

2

g

O

N03AX14

levodropropizine

0.12

g

O

R05DB27

meloxicam

15

mg

P

M01AC06

nonacog alfa

1000

U

P

B02BD09

protionamide

0.75

g

O

J04AD01

quinupristin/dalfopristin

1.5

g

P

J01FG02

rifampicin

0.6

g

P

J04AB02

ribavirin

1

g

O

J05AB04

zoledronic acid

4

mg

P

M05BA08

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 15, 2016